Drug profile · INN
famciclovir
FAMVIR
famciclovir (FAMVIR) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — famciclovir
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 1
- Data quality
- 0.89
Quick answer
famciclovir (FAMVIR) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is famciclovir?
famciclovir (FAMVIR) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for famciclovir?
FAMVIR is a marketed brand name for famciclovir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of famciclovir?
famciclovir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.